These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 9770237)
21. Pas de deux in groups of four--the biogenesis of KATP channels. Neagoe I; Schwappach B J Mol Cell Cardiol; 2005 Jun; 38(6):887-94. PubMed ID: 15910873 [TBL] [Abstract][Full Text] [Related]
22. The sulfonylurea receptor, an atypical ATP-binding cassette protein, and its regulation of the KATP channel. Burke MA; Mutharasan RK; Ardehali H Circ Res; 2008 Feb; 102(2):164-76. PubMed ID: 18239147 [TBL] [Abstract][Full Text] [Related]
23. [The role of sulphonylurea derivatives in treatment of diabetes type 2. The role of glimepiride]. Sieradzki J Przegl Lek; 2000; 57 Suppl 4():13-8. PubMed ID: 11293224 [TBL] [Abstract][Full Text] [Related]
24. Remodelling of the SUR-Kir6.2 interface of the KATP channel upon ATP binding revealed by the conformational blocker rhodamine 123. Hosy E; Dérand R; Revilloud J; Vivaudou M J Physiol; 2007 Jul; 582(Pt 1):27-39. PubMed ID: 17510180 [TBL] [Abstract][Full Text] [Related]
25. Proximal C-terminal domain of sulphonylurea receptor 2A interacts with pore-forming Kir6 subunits in KATP channels. Rainbow RD; James M; Hudman D; Al Johi M; Singh H; Watson PJ; Ashmole I; Davies NW; Lodwick D; Norman RI Biochem J; 2004 Apr; 379(Pt 1):173-81. PubMed ID: 14672537 [TBL] [Abstract][Full Text] [Related]
26. Characterization and significance of sulfonylurea receptors. Siconolfi-Baez L; Banerji MA; Lebovitz HE Diabetes Care; 1990 Aug; 13 Suppl 3():2-8. PubMed ID: 2209340 [TBL] [Abstract][Full Text] [Related]
33. Uncoupling by (--)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP. Jin JY; Park SH; Bae JH; Cho HC; Lim JG; Park WS; Han J; Lee JH; Song DK Pharmacol Res; 2007 Sep; 56(3):237-47. PubMed ID: 17656102 [TBL] [Abstract][Full Text] [Related]
34. An endogenous ligand for the central sulfonylurea receptor. Virsolvy-Vergine A; Brück M; Dufour M; Cauvin A; Lupo B; Bataille D FEBS Lett; 1988 Dec; 242(1):65-9. PubMed ID: 3144466 [TBL] [Abstract][Full Text] [Related]
35. Syntaxin-1A inhibits KATP channels by interacting with specific conserved motifs within sulfonylurea receptor 2A. Chao C; Liang T; Kang Y; Lin X; Xie H; Feng ZP; Gaisano HY J Mol Cell Cardiol; 2011 Nov; 51(5):790-802. PubMed ID: 21884702 [TBL] [Abstract][Full Text] [Related]
36. Multisite phosphorylation mechanism for protein kinase A activation of the smooth muscle ATP-sensitive K+ channel. Quinn KV; Giblin JP; Tinker A Circ Res; 2004 May; 94(10):1359-66. PubMed ID: 15087422 [TBL] [Abstract][Full Text] [Related]
37. Modification of the mitochondrial sulfonylurea receptor by thiol reagents. Szewczyk A; Wójcik G; Lobanov NA; Nalecz MJ Biochem Biophys Res Commun; 1999 Aug; 262(1):255-8. PubMed ID: 10448101 [TBL] [Abstract][Full Text] [Related]
38. Characterization of low-affinity binding sites for glibenclamide on the Kir6.2 subunit of the beta-cell KATP channel. Gros L; Virsolvy A; Salazar G; Bataille D; Blache P Biochem Biophys Res Commun; 1999 Apr; 257(3):766-70. PubMed ID: 10208857 [TBL] [Abstract][Full Text] [Related]
39. [Sulfonylurea receptors and their interaction with glimepiride]. Zueva NA; Sologub NV; Efimov AS Lik Sprava; 2003; (2):35-9. PubMed ID: 12774471 [TBL] [Abstract][Full Text] [Related]
40. Polymeric gene transfection on insulin-secreting cells: sulfonylurea receptor-mediation and transfection medium effect. Kang HC; Bae YH Pharm Res; 2006 Aug; 23(8):1797-808. PubMed ID: 16850268 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]